-
Je něco špatně v tomto záznamu ?
Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice
M. Krupka, K. Zachova, R. Cahlikova, J. Vrbkova, Z. Novak, M. Sebela, E. Weigl, M. Raska,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- antigeny virové imunologie MeSH
- CD8-pozitivní T-lymfocyty imunologie MeSH
- dendritické buňky imunologie MeSH
- endocytóza imunologie MeSH
- endotoxiny imunologie MeSH
- HIV korový protein p24 imunologie metabolismus MeSH
- imunizace MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- nepřímá aktivace imunologie MeSH
- proteiny tepelného šoku HSP70 imunologie metabolismus MeSH
- rekombinantní fúzní proteiny imunologie MeSH
- Th1 buňky imunologie MeSH
- vakcíny proti AIDS imunologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Heat shock proteins hsp70 and gp96 have been confirmed as adjuvants enabling induction of cell- and antibody-mediated immunity specific to associated protein or peptide antigens due to the activation of naive dendritic cells and supporting cross-presentation of associated antigen. An efficacious vaccine preventing HIV-1 infection should induce (1) antibodies neutralizing HIV-1 Env protein, preventing virus spreading and (2) CD4(+) Th1 and CD8(+) T cells specific to viral proteins, especially gag p24, important for elimination of HIV-1 infected cells. As p24 is relatively poorly recognized by dendritic cells, its targeting to DC is important for enhancement of vaccine efficacy. In this study, a p24 protein fused to the C- or N-terminus of murine hsp70 was produced as a recombinant protein and administered without any adjuvant to experimental BALB/c mice. Consequently, p24-specific cellular and humoral immune responses were measured. To minimize the effect of bacterial endotoxin, each protein was subjected to a repeated endotoxin phase extraction until each preparation contained less than 2.5 endotoxin unit (EU) per mg of antigen. In addition, endocytosis of p24 fused to hsp70 by dendritic cells and their activation were characterized. The fusion to hsp70 protein enhanced endocytosis of p24 as well as activation of dendritic cells in vitro. After immunization of mice, hsp70-p24 fusion protein induced the strongest p24-specific CD4(+) and CD8(+) T cells (IFN-γ production) and humoral (IgG2b) responses corresponding to Th1 type dominance, whereas p24-hsp70 or p24 itself induced weaker responses.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010147
- 003
- CZ-PrNML
- 005
- 20160414104616.0
- 007
- ta
- 008
- 160408s2015 ne f 000 0|engg|
- 009
- AR
- 024 7_
- $a 10.1016/j.imlet.2015.05.010 $2 doi
- 024 7_
- $a 10.1016/j.imlet.2015.05.010 $2 doi
- 035 __
- $a (PubMed)26021827
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Krupka, M $u Palacky University in Olomouc, Faculty of Medicine and Dentistry, Department of Immunology, Olomouc, Czech Republic.
- 245 10
- $a Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice / $c M. Krupka, K. Zachova, R. Cahlikova, J. Vrbkova, Z. Novak, M. Sebela, E. Weigl, M. Raska,
- 520 9_
- $a Heat shock proteins hsp70 and gp96 have been confirmed as adjuvants enabling induction of cell- and antibody-mediated immunity specific to associated protein or peptide antigens due to the activation of naive dendritic cells and supporting cross-presentation of associated antigen. An efficacious vaccine preventing HIV-1 infection should induce (1) antibodies neutralizing HIV-1 Env protein, preventing virus spreading and (2) CD4(+) Th1 and CD8(+) T cells specific to viral proteins, especially gag p24, important for elimination of HIV-1 infected cells. As p24 is relatively poorly recognized by dendritic cells, its targeting to DC is important for enhancement of vaccine efficacy. In this study, a p24 protein fused to the C- or N-terminus of murine hsp70 was produced as a recombinant protein and administered without any adjuvant to experimental BALB/c mice. Consequently, p24-specific cellular and humoral immune responses were measured. To minimize the effect of bacterial endotoxin, each protein was subjected to a repeated endotoxin phase extraction until each preparation contained less than 2.5 endotoxin unit (EU) per mg of antigen. In addition, endocytosis of p24 fused to hsp70 by dendritic cells and their activation were characterized. The fusion to hsp70 protein enhanced endocytosis of p24 as well as activation of dendritic cells in vitro. After immunization of mice, hsp70-p24 fusion protein induced the strongest p24-specific CD4(+) and CD8(+) T cells (IFN-γ production) and humoral (IgG2b) responses corresponding to Th1 type dominance, whereas p24-hsp70 or p24 itself induced weaker responses.
- 650 _2
- $a vakcíny proti AIDS $x imunologie $7 D016915
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antigeny virové $x imunologie $7 D000956
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
- 650 _2
- $a nepřímá aktivace $x imunologie $7 D045142
- 650 _2
- $a dendritické buňky $x imunologie $7 D003713
- 650 _2
- $a endocytóza $x imunologie $7 D004705
- 650 _2
- $a endotoxiny $x imunologie $7 D004731
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a HIV korový protein p24 $x imunologie $x metabolismus $7 D016655
- 650 _2
- $a proteiny tepelného šoku HSP70 $x imunologie $x metabolismus $7 D018840
- 650 _2
- $a imunizace $7 D007114
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a rekombinantní fúzní proteiny $x imunologie $7 D011993
- 650 _2
- $a Th1 buňky $x imunologie $7 D018417
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zachova, K $u Palacky University in Olomouc, Faculty of Medicine and Dentistry, Department of Immunology, Olomouc, Czech Republic.
- 700 1_
- $a Cahlikova, R $u Palacky University in Olomouc, Faculty of Medicine and Dentistry, Department of Immunology, Olomouc, Czech Republic.
- 700 1_
- $a Vrbkova, J $u Palacky University in Olomouc, Faculty of Science, Department of Mathematical Analysis and Applications of Mathematics, Olomouc, Czech Republic.
- 700 1_
- $a Novak, Z $u University of Alabama at Birmingham, Birmingham, USA.
- 700 1_
- $a Sebela, M $u Palacky University in Olomouc, Faculty of Science, Centre of the Region Hana for Biotechnological and Agricultural Research, Olomouc, Czech Republic.
- 700 1_
- $a Weigl, E $u Palacky University in Olomouc, Faculty of Medicine and Dentistry, Department of Immunology, Olomouc, Czech Republic.
- 700 1_
- $a Raska, M $u Palacky University in Olomouc, Faculty of Medicine and Dentistry, Department of Immunology, Olomouc, Czech Republic. Electronic address: raskamil@uab.edu.
- 773 0_
- $w MED00002200 $t Immunology letters $x 1879-0542 $g Roč. 166, č. 1 (2015), s. 36-44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26021827 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160414104701 $b ABA008
- 999 __
- $a ok $b bmc $g 1113576 $s 934515
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 166 $c 1 $d 36-44 $e 20150527 $i 1879-0542 $m Immunology letters $n Immunol Lett $x MED00002200
- LZP __
- $a Pubmed-20160408